Immune Response, Safety, and Survival and Quality of Life Outcomes for Advanced Colorectal Cancer Patients Treated with Dendritic Cell Vaccine and Cytokine-Induced Killer Cell Therapy

Purpose. To determine the immune response after dendritic cell (DC) vaccine and cytokine-induced killer cells (CIK) therapy and assess its associated toxicity, survival benefit, and changes in the quality of life (QOL) of advanced colorectal cancer (CRC) patients. Methods. We recruited 100 patients...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhu, Hui, Yang, Xuejing, Li, Jiali, Ren, Yanjie, Zhang, Tianyu, Zhang, Chunze, Zhang, Jintai, Li, Jing, Pang, Yan
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2014
Sujets:
Clinical Study
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124766/
https://ncbi.nlm.nih.gov/pubmed/25136601
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2014/603871
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires